Wedge Industrial (000534) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Jul, 2026Executive summary
Revenue for Q3 2024 reached ¥274.58 million, up 9.16% year-over-year; year-to-date revenue was ¥777.33 million, up 6.91% year-over-year.
Net profit attributable to shareholders for Q3 was ¥40.78 million, up 15.51% year-over-year; year-to-date net profit was ¥138.78 million, up 13.36% year-over-year.
Operating cash flow for Q3 was ¥51.11 million, a significant increase of 357.56% year-over-year.
Financial highlights
Gross margin improved as revenue growth outpaced cost increases.
Basic EPS for Q3 was ¥0.0831, up 19.57% year-over-year; year-to-date basic EPS was ¥0.2806, up 15.90% year-over-year.
Total assets at quarter-end were ¥3.57 billion, up 14.49% from the previous year-end.
Shareholders’ equity attributable to listed company shareholders was ¥1.24 billion, up 1.98% from year-end.
Outlook and guidance
Increased R&D and capital expenditures signal ongoing investment in new projects and capacity.
Management expects continued growth, supported by strong order inflow and strategic investments.
Latest events from Wedge Industrial
- Net profit rose 12.49% YoY on higher revenue and robust pharmaceutical segment growth.000534
Q2 20249 Jul 2026 - Audit confirms accurate related party fund flows and significant intra-group transactions in 2024.000534
Q4 20249 Jul 2026 - Revenue and profit surged, with robust growth in pharma and alloy businesses and strategic investments.000534
Q2 20259 Jul 2026 - Revenue and net profit rose over 10% year-over-year, with robust growth in high-temperature alloys.000534
Q1 20259 Jul 2026 - Revenue and profit surged over 20% year-over-year, led by high-temperature alloy sales.000534
Q3 20259 Jul 2026 - Revenue up 19.62% to ¥1.29B, net profit up 2.22%, with strong R&D and no cash dividend.000534
Q4 20259 Jul 2026 - Q1 2026 saw revenue and profit growth, negative cash flow, and major strategic investment in a subsidiary.000534
Q1 20269 Jul 2026